Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth hormone metabolic effects in children with Kabuki syndrome
NL-OMON22646Recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- May 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of somatropin in Kabuki syndrome, sponsored by Maastricht University Medical Center+. Started May 2012; status: recruiting.
02
Drugs
somatropin
03
Conditions
Kabuki syndrome
Beyond the preview
Go deeper on NL-OMON22646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22646.